Femiprost 250 (Carboprost Tromethamine Tablet) 250 mcg/mcl

Femiprost 250 contains Carboprost Tromethamine, a prostaglandin used for postpartum hemorrhage management. This 250 mcg/mcl tablet supports uterine contraction and bleeding control. Ideal for medical settings requiring rapid intervention. Short-term use only.

Strength

250 mcg/mcl

Pack Size

5 x 1 Amp

Storage

Ambient

Manufacturer / TM Owner

Cadila Healthcare Limited

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Carboprost Tromethamine, the active ingredient in Femiprost 250, is primarily used to treat heavy bleeding after childbirth when other methods are ineffective. It works by causing the uterus to contract strongly, which helps reduce blood loss. This medication is typically administered in clinical environments under professional supervision.

Side Effects

After administration, Femiprost 250 may cause the uterus to tighten, which can help control excessive bleeding. Some individuals may experience mild cramping or nausea as the medication takes effect. These effects are generally temporary and linked to the drug’s mechanism of action.

Precautions & Warnings

Femiprost 250 should only be handled and administered by trained healthcare providers. It is not intended for self-use or home administration. Keep this medication stored at room temperature and away from moisture or direct light. Always check the expiration date before use.

Avoid Interactions

Femiprost 250 may interact with other oxytocic agents or medications that affect uterine tone. Avoid concurrent use with high-dose prostaglandins or certain asthma treatments without medical guidance. Always inform your healthcare provider about all medications currently in use.

References

Frequently Asked Questions

Femiprost 250 is used to manage heavy bleeding after childbirth when standard treatments are insufficient.

It is administered by healthcare professionals in a clinical setting, typically as an injection.

No, this medication requires professional medical supervision for safe and effective use.

Common effects may include cramping, nausea, or vomiting, which are usually temporary.

This medication is used specifically for postpartum bleeding and is not intended for use during pregnancy.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.